PERSPECTA

News from every angle

← Back to headlines

West Pharma Stock Rating Raised by Barclays

Barclays has upgraded West Pharma's stock rating to Overweight, citing strong fundamentals for the company.

9 Jun, 15:28 — 9 Jun, 15:28
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed5d ago

West Pharma raised to Overweight at Barclays on fundamentals

Read full article →

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Philippine Police Intensify Crackdown on Scam Hubs

15m ago

Latvian Company Develops Innovative Phosphorus Pollution Solution

16m ago

BTS Concert Gift Bags Resold Online, Angering Fans

19m ago